José Manuel Nájera Maldonado

Mr. José Manuel Nájera Maldonado

orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 February 2024 in Journal of Xenobiotics
Verified
Journal Article
Open access
PDF file
JMJosé Manuel Nájera Maldonado
José Manuel Nájera Maldonado
RSRicardo Salazar
Ricardo Salazar
PAPatricia Alvarez-Fitz
Patricia Alvarez-Fitz
MAMacdiel Acevedo-Quiroz
Macdiel Acevedo-Quiroz
EFEugenia Flores-Alfaro
Eugenia Flores-Alfaro
MRMonica Ramirez
Monica Ramirez
The number of elderly people is projected to double in the next 50 years worldwide, resulting in an increased prevalence of neurodegenerative diseases. Aging causes changes in brain tissue homeostasis, thus contributing to the development of neurodegenerative disorders. Current treatments are not entirely effective, so alternative treatments or adjuvant agents are being actively sought. Antioxidant properties of phenolic compounds are of particular interest for neurodegenerative diseases whose psychopathological mechanisms strongly rely on oxidative stress at the brain level. Moreover, phenolic compounds display other advantages such as the permeability of the blood–brain barrier (BBB) and the interesting molecular mechanisms that we reviewed in this work. We began by briefly outlining the physiopathology of neurodegenerative diseases to understand the mechanisms that result in irreversible brain damage, then we provided an overall classification of the phenolic compounds that would be addressed later. We reviewed in vitro and in vivo studies, as well as some clinical trials in which neuroprotective mechanisms were demonstrated in models of different neurodegenerative diseases such as amyotrophic lateral sclerosis (ALS), Alzheimer’s disease (AD), Parkinson’s disease (PD), ischemia, and traumatic brain injury (TBI).

31 July 2026 in Journal of Xenobiotics
Verified
Journal Article
Open access
PDF file
JMJosé Manuel Nájera Maldonado
José Manuel Nájera Maldonado
PMPaola Molina-Manzano
Paola Molina-Manzano
EFEugenia Flores-Alfaro
Eugenia Flores-Alfaro
MEMonica Espinoza-Rojo
Monica Espinoza-Rojo
IPIsela Parra-Rojas
Isela Parra-Rojas
MRMonica Ramirez
Monica Ramirez
Simple phenolic compounds can act as antioxidants or prooxidants depending on their structure and environmental conditions. Glutamate-induced excitotoxicity leads to neurodegeneration, astrocyte dysfunction, oxidative stress, and neuroinflammation. This study examined six phenolics: catechol, phloroglucinol, resorcinol, pyrogallol, hydroquinone, and hydroxyquinol, assessing their effects on astrocyte survival in a glutamate-excitotoxic model. Mouse astrocytes (C8-D1A) were exposed to 20 mM glutamate, with phenolics added before, during, or after treatment. Cell viability, morphology, nuclear condensation, ROS levels, and inflammatory cytokines were measured using the MTT assay, microscopy, CellROX, and RT-qPCR. Simultaneously, treatment improved astrocyte survival and preserved morphology, whereas pre- or post-treatment did not confer protection and worsened toxicity at higher doses. Resorcinol showed the strongest protective effect, followed by hydroxyquinol and hydroquinone at lower doses. Resorcinol and hydroxyquinol decreased ROS levels, whereas pyrogallol and hydroquinone increased cell survival without reducing ROS. All four lowered IL-6 and TNF-α. These findings demonstrate that the effects of phenolics, whether protective or toxic, depend on concentration, structure, and timing, underscoring their dual role in excitotoxic environments. They also identify resorcinol as a promising candidate for further preclinical study.